NETCast cover image

Hybrid Neuroendocrine Cancers: Pathology, Grade Transformation, and Emerging Therapies

NETCast

00:00

Hypermutation, Alkylators, and ICI Considerations

Aman Chauhan reviews cases of post-alkylator hypermutation and cautious interest in immunotherapy trials for NECs.

Play episode from 14:33
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app